TRANSFORMED SMALL CELL LUNG CANCER
Clinical trials for TRANSFORMED SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for TRANSFORMED SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare, aggressive lung cancer: experimental drug trial opens
Disease control Not yet recruitingThis study is testing whether a new medicine called PF-08634404 works better when given with standard chemotherapy for transformed small cell lung cancer, a rare and aggressive form of the disease. The trial will enroll 40 adults who haven't received treatment for this specific c…
Matched conditions: TRANSFORMED SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 04, 2026 08:36 UTC
-
New hope for rare, Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing the safety and effectiveness of combining two drugs, lurbinectedin and osimertinib, for a rare and aggressive type of lung cancer called transformed small cell lung cancer. It will involve about 16 adults whose cancer started as one type and changed into thi…
Matched conditions: TRANSFORMED SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Misty Shields • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC